Cargando…
Bebtelovimab-Induced Bradycardia Leading to Cardiac Arrest
Bebtelovimab is a monoclonal antibody used to prevent progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Complications of SARS-CoV-2 infection can include cardiac effects including sinus bradycardia. CASE SUMMARY: We describe the case of an 86-year-old male infect...
Autores principales: | Gearges, Christina, Haider, Hibah, Rana, Vishal, Asghar, Zahra, Kewalramani, Anjali, Kuschner, Zachary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394688/ https://www.ncbi.nlm.nih.gov/pubmed/36003828 http://dx.doi.org/10.1097/CCE.0000000000000747 |
Ejemplares similares
-
Risperidone: Hypothermia, bradycardia and cardiac arrest: 2 case reports
Publicado: (2020) -
Appropriate Strategy for Preventing Bradycardia-induced Cardiac Arrest by Dexmedetomidine
por: Izumida, Toshihide, et al.
Publicado: (2022) -
Bradycardia resulting in cardiac arrest in a critically ill patient receiving dexmedetomidine
por: Bahraini, Anoosh, et al.
Publicado: (2021) -
Bradycardia, Hypotension, and Cardiac Arrest: A Complication of Local Anesthetics
por: Balasanmugam, Cynthia, et al.
Publicado: (2019) -
Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic
por: Nichols, Russell M, et al.
Publicado: (2022)